Angiosoma Stock Market Capitalization
| GSTC Stock | USD 0.0009 0.0001 12.50% |
AngioSoma fundamentals help investors to digest information that contributes to AngioSoma's financial success or failures. It also enables traders to predict the movement of AngioSoma Pink Sheet. The fundamental analysis module provides a way to measure AngioSoma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AngioSoma pink sheet.
AngioSoma |
AngioSoma Company Market Capitalization Analysis
AngioSoma's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current AngioSoma Market Capitalization | 8.47 M |
Most of AngioSoma's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AngioSoma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of AngioSoma is about 8.47 M. This is 99.93% lower than that of the sector and 99.82% lower than that of the Market Capitalization industry. The market capitalization for all United States stocks is 99.96% higher than that of the company.
AngioSoma Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AngioSoma's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of AngioSoma could also be used in its relative valuation, which is a method of valuing AngioSoma by comparing valuation metrics of similar companies.AngioSoma is currently under evaluation in market capitalization category among related companies.
AngioSoma Fundamentals
| Return On Asset | -44.28 | |||
| Current Valuation | 9.39 M | |||
| Shares Outstanding | 770.36 M | |||
| Shares Owned By Insiders | 10.02 % | |||
| Shares Owned By Institutions | 0.02 % | |||
| Price To Sales | 78,201 X | |||
| Gross Profit | (2.41 K) | |||
| EBITDA | (1.21 M) | |||
| Net Income | (1.49 M) | |||
| Cash And Equivalents | 12 | |||
| Total Debt | 20 K | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (327 K) | |||
| Earnings Per Share | (0.02) X | |||
| Price To Earnings To Growth | (0.08) X | |||
| Beta | 1.17 | |||
| Market Capitalization | 8.47 M | |||
| Total Asset | 9 | |||
| Net Asset | 9 |
About AngioSoma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AngioSoma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AngioSoma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AngioSoma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AngioSoma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AngioSoma's short interest history, or implied volatility extrapolated from AngioSoma options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in AngioSoma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for AngioSoma Pink Sheet analysis
When running AngioSoma's price analysis, check to measure AngioSoma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioSoma is operating at the current time. Most of AngioSoma's value examination focuses on studying past and present price action to predict the probability of AngioSoma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AngioSoma's price. Additionally, you may evaluate how the addition of AngioSoma to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |